2019

The Health Resources & Services Administration (“HRSA”) Office of Pharmacy Affairs recently launched an online tool that…

The Affordable Care Act, which was passed in 2010, required the Centers for Medicare & Medicaid Services (“CMS”) to establish…

On May 6, the New Jersey Attorney General, Gurbir S. Grewal, finalized and made effective amendments to the rules governing…

On April 30, 2019, US WorldMeds LLC (“USWM”) agreed to pay $17.4 million to resolve Department of Justice (“DOJ”) allegations that…

The Massachusetts law that permits the use of pharmaceutical manufacturer drug coupons is on life support. The law was set to…

On April 23, 2019, the Manhattan U.S. Attorney and N.Y. Division of the Drug Enforcement Administration announced the “first ever…

On March 28, 2019, the Federal Trade Commission (“FTC”) issued an Opinion and Final Order against Impax Laboratories LLC…

On April 25, 2019,  Astellas Pharma US Inc. (“Astellas”) and Amgen Inc. (“Amgen”) agreed to pay a combined $125.75 million to…

On March 26, 2019, Purdue Pharma LP, the manufacturer of OxyContin, together with the Sackler family who own the company, agreed…

Here in the US, there has been a tremendous amount of discussion in recent years about the soaring cost of prescription drugs, and…